By Mill Chart
Last update: Feb 26, 2025
In this article we will dive into TURKCELL ILETISIM HIZMET-ADR (NYSE:TKC) as a possible candidate for growth investing. Investors should always do their own research, but we noticed TURKCELL ILETISIM HIZMET-ADR showing up in our CANSLIM growth screen, which makes it worth to investigate a bit more.
ChartMill utilizes a proprietary algorithm to assign a Technical Rating to every stock. This rating, ranging from 0 to 10, is computed daily by analyzing a variety of technical indicators and properties.
We assign a technical rating of 7 out of 10 to TKC. This is due to a consistent overall performance, although we see some doubts in the very recent evolution. In the medium time frame things are still looking good.
For an up to date full technical analysis you can check the technical report of TKC
As part of its analysis, ChartMill provides a comprehensive Fundamental Rating for each stock. This rating, ranging from 0 to 10, is updated on a daily basis and is based on the evaluation of various fundamental indicators and properties.
Overall TKC gets a fundamental rating of 7 out of 10. We evaluated TKC against 22 industry peers in the Wireless Telecommunication Services industry. Both the profitability and the financial health of TKC get a neutral evaluation. Nothing too spectacular is happening here. TKC is growing strongly while it also seems undervalued. This is an interesting combination With these ratings, TKC could be worth investigating further for value and growth investing!.
Check the latest full fundamental report of TKC for a complete fundamental analysis.
More ideas for growth investing can be found on ChartMill in our CANSLIM screen.
Important Note: The content of this article is not intended as trading advice. It is essential to perform your own analysis and exercise caution when making trading decisions. The article presents observations created by automated analysis but does not guarantee any trading or investment outcomes. Always trade responsibly and make independent judgments.
7.24
0 (0%)
Find more stocks in the Stock Screener
Based on fundamental analysis, it turns out that TURKCELL ILETISIM HIZMET-ADR (NYSE:TKC) may be suited for growth investing, we'll explore why in this article.